FFCP PHASE1:Mm9::chr2:164062968..164062975,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=44|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:164062968..164062975,-|id=chr2:164062968..164062975,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000998!2.87e-30!1;UBERON:0007194!2.87e-30!1;UBERON:0006868!2.87e-30!1;UBERON:0010147!6.78e-16!2;UBERON:0003937!6.78e-16!2;UBERON:0005399!6.78e-16!2;UBERON:0000080!1.23e-08!4;UBERON:0005904!1.23e-08!4;UBERON:0006947!1.23e-08!4;UBERON:0002120!1.23e-08!4;UBERON:0004054!1.23e-08!4;UBERON:0004875!1.23e-08!4;UBERON:0004876!1.23e-08!4;UBERON:0005721!1.23e-08!4;UBERON:0005754!1.23e-08!4;UBERON:0007297!1.23e-08!4|ontology_enrichment_uberon_v019_2=UBERON:0000998,2.74e-44,1;UBERON:0007194,2.74e-44,1;UBERON:0006868,2.74e-44,1;UBERON:0010147,5.75e-23,2;UBERON:0003937,5.75e-23,2;UBERON:0005399,5.75e-23,2;UBERON:0000080,3.12e-12,4;UBERON:0005904,3.12e-12,4;UBERON:0006947,3.12e-12,4;UBERON:0002120,3.12e-12,4;UBERON:0004054,3.12e-12,4;UBERON:0004875,3.12e-12,4;UBERON:0004876,3.12e-12,4;UBERON:0005721,3.12e-12,4;UBERON:0005754,3.12e-12,4;UBERON:0007297,3.12e-12,4;UBERON:0000058,1.41e-07,7|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,1.1418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.6241962187937,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:164062968..164062975,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=44 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr2:164062968..164062975,- | |||
|description=CAGE_peak_at_chr2:164062968..164062975,- | |||
|id=chr2:164062968..164062975,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000998!2.87e-30!1;UBERON:0007194!2.87e-30!1;UBERON:0006868!2.87e-30!1;UBERON:0010147!6.78e-16!2;UBERON:0003937!6.78e-16!2;UBERON:0005399!6.78e-16!2;UBERON:0000080!1.23e-08!4;UBERON:0005904!1.23e-08!4;UBERON:0006947!1.23e-08!4;UBERON:0002120!1.23e-08!4;UBERON:0004054!1.23e-08!4;UBERON:0004875!1.23e-08!4;UBERON:0004876!1.23e-08!4;UBERON:0005721!1.23e-08!4;UBERON:0005754!1.23e-08!4;UBERON:0007297!1.23e-08!4 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000998,2.74e-44,1;UBERON:0007194,2.74e-44,1;UBERON:0006868,2.74e-44,1;UBERON:0010147,5.75e-23,2;UBERON:0003937,5.75e-23,2;UBERON:0005399,5.75e-23,2;UBERON:0000080,3.12e-12,4;UBERON:0005904,3.12e-12,4;UBERON:0006947,3.12e-12,4;UBERON:0002120,3.12e-12,4;UBERON:0004054,3.12e-12,4;UBERON:0004875,3.12e-12,4;UBERON:0004876,3.12e-12,4;UBERON:0005721,3.12e-12,4;UBERON:0005754,3.12e-12,4;UBERON:0007297,3.12e-12,4;UBERON:0000058,1.41e-07,7 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,1.1418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39.6241962187937,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:164062968..164062975,- | |||
}} |
Latest revision as of 11:51, 4 August 2015
Short description: | p@chr2:164062968..164062975, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:164062968..164062975, - |
Coexpression cluster: | MCL_coexpression_mm9:44 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
seminal vesicle | 2.74e-44 | 1 |
vesicular gland | 2.74e-44 | 1 |
seminal fluid secreting gland | 2.74e-44 | 1 |
male accessory sex gland | 5.75e-23 | 2 |
sex gland | 5.75e-23 | 2 |
male reproductive gland | 5.75e-23 | 2 |
mesonephros | 3.12e-12 | 4 |
duct of male reproductive system | 3.12e-12 | 4 |
male genital duct | 3.12e-12 | 4 |
pronephros | 3.12e-12 | 4 |
internal male genitalia | 3.12e-12 | 4 |
nephrogenic cord | 3.12e-12 | 4 |
urogenital ridge | 3.12e-12 | 4 |
pronephric mesoderm | 3.12e-12 | 4 |
rostral part of nephrogenic cord | 3.12e-12 | 4 |
presumptive pronephric mesoderm | 3.12e-12 | 4 |
duct | 1.41e-07 | 7 |